# Gevo, Inc.: overview GEVO · Nasdaq · CIK 1392380 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/gevo.md) · [Financials](/companies/gevo/financials.md) · [Filings](/companies/gevo/filings.md) · [Insiders](/companies/gevo/insiders.md) Latest reported revenue: [$46.5m](/filings/0001628280-26-054462.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-054462). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [2.0](/filings/0001392380-25-000032.md) | [5.7 d](/filings/0001392380-26-000006.md) | [29.1](/filings/0001392380-26-000016.md) | [43.4](/filings/0001628280-26-054462.md) | [42.7](/filings/0001392380-25-000032.md) | [45.3 d](/filings/0001392380-26-000006.md) | [42.9](/filings/0001392380-26-000016.md) | [46.5](/filings/0001628280-26-054462.md) | | Gross margin | % | not reported | not reported | not reported | [43.6%](/filings/0001628280-26-054462.md) | not reported | not reported | not reported | [42.6%](/filings/0001628280-26-054462.md) | | Operating margin | % | [(1221.8%)](/filings/0001392380-25-000032.md) | [(344.7%) d](/filings/0001392380-26-000006.md) | [(69.2%)](/filings/0001392380-26-000016.md) | [13.4%](/filings/0001628280-26-054462.md) | [(8.6%)](/filings/0001392380-25-000032.md) | [(4.8%) d](/filings/0001392380-26-000006.md) | [(11.4%)](/filings/0001392380-26-000016.md) | [(369.3%)](/filings/0001628280-26-054462.md) | | Net margin | % | [(1076.6%)](/filings/0001392380-25-000032.md) | [(308.9%) d](/filings/0001392380-26-000006.md) | [(74.6%)](/filings/0001392380-26-000016.md) | [4.9%](/filings/0001628280-26-054462.md) | [(18.6%)](/filings/0001392380-25-000032.md) | [(13.9%) d](/filings/0001392380-26-000006.md) | [(50.5%)](/filings/0001392380-26-000016.md) | [(380.5%)](/filings/0001628280-26-054462.md) | | Diluted EPS | $ per share | [(0.09)](/filings/0001392380-25-000032.md) | not reported | [(0.09)](/filings/0001392380-26-000016.md) | [0.01](/filings/0001628280-26-054462.md) | [(0.03)](/filings/0001392380-25-000032.md) | not reported | [(0.09)](/filings/0001392380-26-000016.md) | [(0.75)](/filings/0001628280-26-054462.md) | | Free cash flow | $m | [(20.8) d](/filings/0001392380-25-000032.md) | [(33.5) d](/filings/0001392380-26-000006.md) | [(29.9)](/filings/0001392380-26-000016.md) | [(7.8) d](/filings/0001628280-26-054462.md) | [(14.6) d](/filings/0001392380-25-000032.md) | [8.7 d](/filings/0001392380-26-000006.md) | [(30.0)](/filings/0001392380-26-000016.md) | [(20.8) d](/filings/0001628280-26-054462.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Gross profit: us-gaap:GrossProfit. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.5](/filings/0001392380-23-000013.md) | [1.2](/filings/0001392380-24-000008.md) | [17.2](/filings/0001392380-25-000011.md) | [16.9](/filings/0001392380-26-000006.md) | [161](/filings/0001392380-26-000006.md) | | Gross margin | % | [(2149.0%)](/filings/0001437749-22-004346.md) | not reported | not reported | not reported | not reported | | Operating margin | % | [(11307.3%)](/filings/0001392380-23-000013.md) | [(8739.2%)](/filings/0001392380-24-000008.md) | [(475.8%)](/filings/0001392380-25-000011.md) | [(536.9%)](/filings/0001392380-26-000006.md) | [(12.6%)](/filings/0001392380-26-000006.md) | | Net margin | % | [(11107.5%)](/filings/0001392380-23-000013.md) | [(8341.0%)](/filings/0001392380-24-000008.md) | [(385.0%)](/filings/0001392380-25-000011.md) | [(464.9%)](/filings/0001392380-26-000006.md) | [(21.1%)](/filings/0001392380-26-000006.md) | | Diluted EPS | $ per share | [(0.30)](/filings/0001392380-23-000013.md) | [(0.44)](/filings/0001392380-24-000008.md) | [(0.28)](/filings/0001392380-25-000011.md) | [(0.34)](/filings/0001392380-26-000006.md) | [(0.14)](/filings/0001392380-26-000006.md) | | Free cash flow | $m | [(105)](/filings/0001392380-23-000013.md) | [(128)](/filings/0001392380-24-000008.md) | [(108)](/filings/0001392380-25-000011.md) | [(108)](/filings/0001392380-26-000006.md) | [(43.5)](/filings/0001392380-26-000006.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gevo/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $27.5m | 18,328,928 | | Added +1,007,913 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $20.1m | 13,430,525 | | Added +4,364,606 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $15.4m | 10,254,327 | | Added +120,687 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $9.4m | 6,273,452 | | Added +391,945 | | [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $8.4m | 5,576,328 | | Added +2,226,428 | | [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $8.2m | 5,473,749 | | Added +369,974 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $5.0m | 3,346,604 | | Added +1,160,992 | | [First Bank & Trust](/funds/1692632.md) | 2026-06-30 | $4.6m | 3,064,948 | | Unchanged | | [Nuveen, LLC](/funds/1871926.md) | 2026-06-30 | $4.2m | 2,807,106 | | Reduced −796,501 | | [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $3.3m | 2,204,055 | | Added +17,351 | ## Recent filings [All 1,806 filings](/companies/gevo/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-26 | 09:05 ET | [8-K](/filings/0001104659-26-101084.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-101084 | | 2026-08-06 | 17:08 ET | [10-Q](/filings/0001628280-26-054462.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054462 | | 2026-08-06 | 16:04 ET | [8-K](/filings/0001628280-26-054278.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-054278 | | 2026-07-16 | 08:36 ET | [8-K](/filings/0001104659-26-084096.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-084096 | | 2026-07-15 | 08:35 ET | [8-K](/filings/0001104659-26-083740.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-083740 | | 2026-05-26 | 16:05 ET | [8-K](/filings/0001104659-26-066257.md) | 5.07 Shareholder vote results | 0001104659-26-066257 | | 2026-05-07 | 16:27 ET | [10-Q](/filings/0001392380-26-000016.md) | Quarterly report, period 2026-03-31 | 0001392380-26-000016 | | 2026-05-07 | 16:03 ET | [8-K](/filings/0001392380-26-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001392380-26-000012 | | 2026-04-27 | 16:05 ET | [8-K](/filings/0001104659-26-049429.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-049429 | | 2026-04-15 | 17:15 ET | [8-K](/filings/0001104659-26-043850.md) | 8.01 Other events | 0001104659-26-043850 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001392380-26-000006.md), filed Mar 5, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/a57befe1-67b3-4293-9903-a07cc94faba3) ## About the filer - CIK: 1392380 - Tickers: GEVO - Exchange: Nasdaq - SIC code: 2860 Industrial Organic Chemicals - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 28, 2026, 08:13 ET. No prices; not investment advice.